Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

(2012) Masayoshi Takeuchi et al.   CURRENT DRUG TARGETS

Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees

(2011) Hideki Hiraiwa et al.   INFLAMMATION RESEARCH

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

(2010) Sho-ichi Yamagishi   EXPERIMENTAL GERONTOLOGY

Statistical analyses of ocular inflammatory diseases at Saitama Red Cross Hospital (2003–2007)

(2010) Hidetoshi Kawashima et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products

(2010) Jun-Ichi Takino et al.   Journal of Oncology

Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen

(2009) Kuo-Chu Chang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Clinical features of intraocular inflammation in Hokkaido, Japan

(2008) Hirokuni Kitamei et al.   ACTA OPHTHALMOLOGICA

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease

(2008) Masayoshi Takeuchi et al.   CURRENT PHARMACEUTICAL DESIGN

Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells

(2008) Keiko Iwamoto et al.   JOURNAL OF GASTROENTEROLOGY